A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.
A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.
Not yet recruiting · NCT06928363 · Registry updated 2025-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors. | Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2025-04-15 | NCT06928363 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||